Author

M. R. Leidinger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell type annotation· 2 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:genetic perturbation / CRISPR· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

D. K. Meyerholz· 4 shared C. A. Kaemmer· 2 shared C. Wohlford-Lenane· 2 shared D. E. Quelle· 2 shared M. E. Ortiz Bezara· 2 shared P. B. McCray· 2 shared A. A. Pezzulo· 1 shared A. K. Verma· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

D. K. Meyerholz

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo

J. L. Kohlmeyer, C. A. Kaemmer, J. J. Lingo, M. R. Leidinger, D. K. Meyerholz, M. R. Tanas, R. D. Dodd, D. E. Quelle

This study shows RABL6A promotes NF1-associated MPNST progression in vivo, with loss of RABL6A leading to slower tumor growth and upregulated p27, but also paradoxical Myc elevation and hyper-proliferative tumors.

bioRxiv · Jul 7, 2021Cancer Biology

RABL6A promotes pancreatic neuroendocrine tumor angiogenesis and progression in vivo

C. K. Maharjan, C. A. Kaemmer, V. P. Muniz, C. Bauchle, S. L. Mott, K. D. Zamba, P. Breheny, M. R. Leidinger, B. W. Darbro, S. Stephens, D. K. Meyerholz, D. E. Quelle

This study shows RABL6A promotes pancreatic neuroendocrine tumor angiogenesis and progression in vivo by affecting tumor formation, angiogenesis, and survival.

bioRxiv · Mar 17, 2021Cancer Biology

K18-hACE2 Mice for Studies of COVID-19 Treatments and Pathogenesis Including Anosmia

S. Perlman, J. Zheng, L. Y. R. WONG, K. Li, A. K. Verma, M. E. Ortiz Bezara, C. Wohlford-Lenane, M. R. Leidinger, M. C. Kundson, D. K. Meyerholz, P. B. McCray

This study uses K18-hACE2 mice to demonstrate severe SARS-CoV-2 infection in lungs and brains, thrombosis in severe cases, and the protective effect of convalescent plasma against lethal disease, while showing anosmia occurs independently of clinical outcome.

bioRxiv · Aug 7, 2020Microbiology

Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract

M. E. Ortiz Bezara, A. Thurman, A. A. Pezzulo, M. R. Leidinger, J. A. Klesney-Tait, P. H. Karp, P. Tan, C. Wohlford-Lenane, P. B. McCray, D. K. Meyerholz

This study examines ACE2 protein expression in the human respiratory tract using single-cell RNA sequencing and immunohistochemistry, finding it highest in sinonasal cavity and alveoli, and not correlated with severe COVID-19 risk factors.

bioRxiv · Apr 22, 2020Cell Biology